MRNS Marinus Pharma Operating Profitability

MRNS (Marinus Pharmaceuticals) - company brandmark

Marinus Pharmaceuticals (MRNS) operates in a defensive sector where demand for healthcare remains independent of macroeconomic conditions. The current operating margin reflects local dynamics, with its value recorded at -389.70. The company develops therapies to combat rare epilepsy seizures, and its patent portfolio enables the scaling of drug sales globally with minimal costs.

marinuspharma.com (MRNS): Operating Sales Margin from 07/04/2022 to 02/22/2025

Analytical breakdowns for Marinus Pharmaceuticals

- share price and consensus valuation forecast:
Fundamental company analysis:Marinus Pharmaceuticals Inc
Finished products of Marinus Pharma

Marinus Pharmaceuticals' monopoly in the therapy of rare forms of epilepsy via the drug Ganaxolone determines the efficiency of managing development and commercialization costs. The adjusted operating margin, expressing the ratio of core operating profit to revenue, allows for an assessment of the business's ability to generate cash flow before tax payments, where an upward trend confirms the scalability of the business model and the growing investment attractiveness of the asset.

Main competitors

Operating Sales Margin BIIB|NBIX: Operating Profit Rate|Operating Profitability Regencell Bioscience Ltd (RGC)|Operating Margin axsome.com (AXSM)|Operating Margin ACAD (acadia-pharm.com)|XENE - Operating Sales Margin|vikingtherapeutics.com - Operating Margin|Supernus Pharma (SUPN) - Operating Sales Margin|CPRX: Operating Margin|Denali Therapeutics Inc. (DNLI) - Operating Margin|Operating Profitability Harmony Pharma|Operating Profitability BHVN|Operating Sales Margin AMLX (Amylyx Pharmaceuticals, Inc.)|Operating Sales Margin Trevi Corp TRVI|Operating Profitability praxismedicines.com PRAX|AVXL - Operating Sales Margin|CeriBell EEG - Operating Margin|Operating Return on Sales prothena.com|Alector Therapeutics (ALEC) - Operating Profitability|Annexon Biosciences Inc. - Operating Profit Rate|OMER (Omeros Corp) - Operating Margin|Operating Margin neurogene.com|Operating Margin ACIU|VYGR - Operating Return on Sales|Operating Profitability Neumora Therapeutics Inc NMRA|Profitability of Operations Scilex Holding Co. (SCLX)|TVGN - Operating Profitability|Operating Return on Sales alphacognition.com|CGTX (Cognition Therapeutics, Inc.) - Operating Sales Margin|IKT: Operating Profit Ratio|Operating Profitability Cassava Sciences, Inc.|ASRT (assertiotx.com) - Operating Profit Ratio|Operating Profitability Coya (COYA)|VTGN - Operating Return on Sales|Operating Margin OVID (Ovid Therapeutics)|Acumen Pharma (ABOS) - Operating Return on Sales|cervomed.com - Operating Margin|Operating Profit Rate ATHE (Alterity Therapeutics Limited)|CLNN: Operating Margin|Operating Sales Margin PepGen Inc.|JUNS (Jupiter Neurosciences, Inc.) - Operating Margin|Operating Return on Sales Relmada Therapeutics Inc RLMD|Operating Profitability Annovis Bio Corporation (ANVS)|GRCE - Operating Return on Sales|Operating Profitability Firefly Neuroscience, Inc. AIFF|Klotho Neurosciences Inc (KLTO) - Operating Return on Sales|NeuroSense Therapeutics, Ltd. - Operating Margin|RVPH: Operating Profitability|MTVA: Operating Margin|NRXS - Profitability of Operations|HSDT (Helius Medical Technologies Inc.) - Operating Margin|Operating Return on Sales Passage Bio PASG|Operating Profitability Neuphoria (NEUP)|Operating Margin Minerva Neurosciences Corp (NERV)|Operating Profitability Athira ATHA|Operating Margin Addex ADXN|Alzamend - Operating Margin|Operating Return on Sales Cyclerion Therapeutics, Inc.|Protagenic Therapeutics (PTIX) - Operating Profitability|KTTA: Operating Profit Ratio|Operating Sales Margin CRGT|Avenue Therapeutics, Inc - Operating Profit Margin|Operating Profitability Brainstorm Cell (BCLI)|CARA: Operating Profit Margin|Chromocell Therapeutics Corp. - Operating Sales Margin|Profitability of Operations Eliem (ELYM)|ITCI: Operating Sales Margin|Operating Profit Rate LBPH (Longboard)|NKGN (nkgenbiotech.com) - Operating Sales Margin|Operating Sales Margin NeuroBo Pharmaceuticals|SAGE (Sage Therapeutics Inc.) - Operating Margin|Neurotrope - Operating Profit Margin|Operating Margin TRVN|Profitability of Operations Vigil Neuroscience, Inc.|Operating Profitability Anew Medical, Inc. WENA|CERE - Operating Sales Margin